REASON 1 Trial: Sonography in Cardiac Arrest

NCT ID: NCT01446471

Last Updated: 2015-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

793 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-01-31

Study Completion Date

2015-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to investigate the predictive value of the presence or absence of cardiac activity by bedside ultrasound during cardiac arrest. The investigators anticipate based on previous research that patients who suffer a cardiac arrest and have cardiac activity on bedside ultrasound will have a greater chance of surviving to hospital admission. The investigators hypothesis is that the mortality rate in patients in cardiac arrest with no cardiac activity by ultrasound will have a mortality rate of 100%.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a multi-center, prospective, observational trial involving sites across the United States and Canada. Patients will be enrolled through the emergency department either presenting in cardiac arrest, or going into cardiac arrest while in the emergency department. Patients who develop cardiac arrest as inpatients will also be enrolled at centers capable of enrolling inpatients subjects. Advanced Cardiac Life Support (ACLS) protocols and institutional policies for resuscitation will be followed, as is the current standard of care. A patient encounter will conclude upon halting of cardiopulmonary resuscitation. Final disposition of the patient will be evaluated by chart review.

After the initial cardiac arrest and disposition there will be no further direct patient interactions as part of the study except in the setting of repeat cardiac arrest. Patients that have a repeat arrest can undergo a repeated ultrasound exam if they continue to meet inclusion criteria. The repeat episode will be recorded as a continuation of the event and not as a separate enrollment.

Subject data, with Protected Health Information (PHI) removed, will be uploaded into the REDcap web-based database as soon as possible and within 7 days of final disposition. Data will be obtained from initial patient encounter, patient records, and EMS records when available. Additional data may be obtained by chart review to obtain data points not available at initial contact. Individual sites will keep secured records to enable identification of the patient source if data review is required.

Patient information will include 6 types of data, past medical history, events surrounding the cardiac arrest, actions taken by health care professionals, peri-arrest presentation, peri-arrest interventions, and patient outcomes. Health care professional actions can include ACLS medication administration, airway management, chest compressions, defibrillation, pacing, and other resuscitative interventions. Specific data points are listed in the paper version of electronic Case Report Form, CRF, see Appendix A.

Sonography will not hinder or impair resuscitative efforts in any way, including halting CPR or prolonging pauses in cardiopulmonary rescusitation (CPR). Sonographic images will be obtained during designated pauses in chest compressions, as is routine care, during CPR for pulse checks, rhythm checks, and necessary resuscitative procedures.

Single or multi-view echocardiography will be performed as appropriate to obtain diagnostic information for each particular patient during resuscitative efforts. Recording of the image loops will be performed during image acquisition according to standard technology availability at each site. To facilitate image acquisition, the ultrasound probe may be placed in the epigastrium or parasternal region during CPR with the heart centered in the field of view, if it will not interfere with ongoing resuscitation. Recording of the images can begin immediately upon pauses of CPR using whatever means are available at the site. Sonographic images will be obtained by competent personnel with experience in bedside cardiac ultrasound. This information will be made available to the physician taking care of the patient

Ultrasound images will consist of a single or multiple view(s) that can include subxiphoid, parasternal long axis, and/or apical 4 chamber. While not primarily preferred views; also acceptable are parasternal short axis or apical 2 chamber views. Image requirements will be based on adequate echocardiographic windows and adequate image acquisition as determined by the physician performing the bedside ultrasound. In the setting of difficult to image patients a combination of views may be required to obtain adequate information.

There will be at least two ultrasound exams performed. The initial ultrasound exam and video will be obtained upon the first pause for pulse or rhythm check once the inclusion criteria are met and no exclusion criteria are present. The final ultrasound exam and video will be obtained when resuscitative efforts are halted.

All ultrasound images will be recorded for later review by the Regional Coordinating Site for each Local Site. Ultrasound videos will be interpreted during acquisition as cardiac activity present or absent and valvular movement present or absent. Specific video file formats that are acceptable include MPEG4, Quicktime (MOV), DV, AVI, and WMV. Files will be forwarded at least monthly to the Site Coordinator for the Regional Site and sent within 1 week of request by the regional coordinating site.

INITIAL INTERPRETATION OF CARDIAC IMAGES The Local Site PI will interpret ultrasound images and the information will be uploaded into the central database or another database specified by the Central Coordinating Site. Cardiac activity will initially categorize as "Cardiac Activity Present", "Cardiac Activity Absent", Valve Movement Present", or Valve Movement Absent". Cardiac activity is defined as any intrinsic movement of the myocardium, but not isolated movement of the cardiac valves. Valve movement is defined as any movement of the cardiac valves.

FINAL INTERPRETATION OF CARDIAC IMAGES

Cardiac images will be reviewed by regional site PIs for sub-categories of cardiac activity. A heart with any intrinsic cardiac movement outside of isolated valvular motion will be categorized as "Cardiac Activity Present". Ultrasound images in patients with cardiac activity will be further categorized as:

1. Cardiac motion but No decrease in chamber size
2. Cardiac motion with a decrease in chamber size \<10%
3. Cardiac motion with a decrease in chamber size of \>10%.

The estimated duration that each subject will participate is the length of the cardiopulmonary resuscitation which can vary by patient, but can be from 15 minutes to 1 hour, with later follow up (hours to days later) to determine final disposition.

A summary of the sequence and duration of all research activities is as follows.

Patient interactions (estimated 15 minutes to 1 hour)

* Patient identified to be in cardiac arrest with confirmation of no pulse.
* Chest compressions and ACLS protocols initiated as per standard care
* Bedside ultrasound of heart performed and interpreted during standard pauses in cardiac compressions as per routine care at institution (3-6 seconds)
* ACLS protocols continue as per standard care by treating physician
* Resuscitation activities halted by either pronouncement of patient or return of spontaneous circulation allowing disposition planning
* Bedside ultrasound of heart performed and interpreted (3-6 seconds)

Data Acquisition (Immediate to days later via chart review)

* Final patient disposition determined
* Interval events recorded (ie: repeat cardiopulmonary arrest)

Data Management (immediate to days or weeks later)

* Subject data with PHI removed entered into research database
* Subject data with PHI removed updated in research database if CRF not completed initially
* Cardiac ultrasound images with PHI removed sent to regional site for review

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Arrest Pulseless Electrical Activity Asystole

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cardiac Arrest

Patients in Cardiac Arrest will be enrolled

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients in cardiac arrest with no pulse

Exclusion Criteria

* Patients with isolated ventricular fibrillation as their cardiac rhythm at the time of presentation
* Traumatic cardiopulmonary arrest
* Ultrasound system or physician experienced in bedside cardiac ultrasound not available
* Resuscitative efforts halted due to end of life decisions or designations
* Attending physician of record declines enrollment of patient
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

North Shore University Hospital

OTHER

Sponsor Role collaborator

NYU Langone Health

OTHER

Sponsor Role collaborator

Mount Sinai Hospital, New York

OTHER

Sponsor Role collaborator

Washington University School of Medicine

OTHER

Sponsor Role collaborator

University of New Mexico

OTHER

Sponsor Role collaborator

Wake Forest University Health Sciences

OTHER

Sponsor Role collaborator

University of California, Irvine

OTHER

Sponsor Role collaborator

University of Utah

OTHER

Sponsor Role collaborator

Carolinas Medical Center

OTHER

Sponsor Role collaborator

Emory University

OTHER

Sponsor Role collaborator

Louisiana State University Health Sciences Center in New Orleans

OTHER

Sponsor Role collaborator

Duke University

OTHER

Sponsor Role collaborator

Brigham and Women's Hospital

OTHER

Sponsor Role collaborator

Massachusetts General Hospital

OTHER

Sponsor Role collaborator

Rhode Island Hospital

OTHER

Sponsor Role collaborator

Christiana Care Health Services

OTHER

Sponsor Role collaborator

George Washington University

OTHER

Sponsor Role collaborator

Kingston Health Sciences Centre

OTHER

Sponsor Role collaborator

University of Ottawa

OTHER

Sponsor Role collaborator

Jewish General Hospital

OTHER

Sponsor Role collaborator

Horizon Health Network

OTHER

Sponsor Role collaborator

York Hospitals

OTHER

Sponsor Role collaborator

Boston Medical Center

OTHER

Sponsor Role collaborator

Indiana University

OTHER

Sponsor Role collaborator

Yale University

OTHER

Sponsor Role collaborator

Queen's Medical Center

OTHER

Sponsor Role collaborator

University of Hawaii

OTHER

Sponsor Role collaborator

Stanford University

OTHER

Sponsor Role collaborator

University of Massachusetts, Worcester

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Romolo Gaspari

Director, Division of Emergency Ultrsound

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Romolo Gaspari, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

UMass Memorial Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Christiana Health Care

Newark, Delaware, United States

Site Status

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status

UMASS Memorial Medical Center

Worcester, Massachusetts, United States

Site Status

Washington University Hospital

St Louis, Missouri, United States

Site Status

Northshore University Hospital

Manhasset, New York, United States

Site Status

Carolinas Medical Center

Charlotte, North Carolina, United States

Site Status

University of Ottowa

Ottowa, , Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REASON01

Identifier Type: -

Identifier Source: org_study_id